NCT06734897 Impact of Music Therapy on Speech Intelligibility in Noise With Cochlear Implants
| NCT ID | NCT06734897 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Armina Kreuzer |
| Condition | Music Therapy After Cochlear Implantation |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-06-11 |
| Primary Completion | 2027-02-28 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-06-11 with a primary completion date of 2027-02-28.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this clinical study is to investigate whether six months of music therapy immediately after CI implantation helps to improve speech intelligibility in noise. To investigate the effect of music therapy, a randomized study will be conducted with a "start group A" and a "delayed group" B (control group 1). Group A will start six months of music therapy immediately after cochlear implantation, group B six months later. A further control group 2 will not receive any music therapy. The speech intelligibility values resulting from the OLSA sentence test will be compared between the three groups after six and twelve months.
Eligibility Criteria
Inclusion Criteria: 1. Patient aged between 18-85 years 2. Patients who undergo a new CI Implantation 3. Patients who speak German as their main language Exclusion Criteria: 1\. Patients with congenital deafness
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06734897 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Music Therapy After Cochlear Implantation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06734897 currently recruiting?
Yes, NCT06734897 is actively recruiting participants. Contact the research team at Armina.Kreuzer@luks.ch for enrollment information.
Where is the NCT06734897 trial being conducted?
This trial is being conducted at Lucerne, Switzerland.
Who is sponsoring the NCT06734897 clinical trial?
NCT06734897 is sponsored by Armina Kreuzer. The trial plans to enroll 30 participants.